vs
Healthpeak Properties(DOC)与纽约人寿(UVE)财务数据对比。点击上方公司名可切换其他公司
Healthpeak Properties的季度营收约是纽约人寿的1.8倍($702.9M vs $393.6M),Healthpeak Properties净利率更高(51.6% vs 13.8%,领先37.8%),纽约人寿同比增速更快(-0.3% vs -6.6%),过去两年纽约人寿的营收复合增速更高(1.7% vs 0.5%)
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金,核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建,总部设在科罗拉多州丹佛市,在尔湾、纳什维尔、旧金山均设有办事处,截至2019年12月31日共持有617处物业的权益。
纽约人寿(全称纽约人寿保险公司)是美国第二大人寿保险公司,也是美国规模最大的相互制人寿保险公司,在2025年《财富》美国500强总营收榜单中位列第69位。2025年,纽约人寿获得了四家独立评级机构给出的最高评级,旗下关联机构还提供各类证券产品与服务及其他相关业务。
DOC vs UVE — 直观对比
营收规模更大
DOC
是对方的1.8倍
$393.6M
营收增速更快
UVE
高出6.3%
-6.6%
净利率更高
DOC
高出37.8%
13.8%
两年增速更快
UVE
近两年复合增速
0.5%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $702.9M | $393.6M |
| 净利润 | $363.0M | $54.3M |
| 毛利率 | — | — |
| 营业利润率 | 0.7% | — |
| 净利率 | 51.6% | 13.8% |
| 营收同比 | -6.6% | -0.3% |
| 净利润同比 | 28.3% | — |
| 每股收益(稀释后) | $0.28 | $1.88 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
DOC
UVE
| Q1 26 | $702.9M | $393.6M | ||
| Q4 25 | $719.4M | $407.9M | ||
| Q3 25 | $705.9M | $401.0M | ||
| Q2 25 | $694.3M | $400.1M | ||
| Q1 25 | $702.9M | $394.9M | ||
| Q4 24 | $698.0M | $384.8M | ||
| Q3 24 | $700.4M | $387.6M | ||
| Q2 24 | $695.5M | $380.2M |
净利润
DOC
UVE
| Q1 26 | $363.0M | $54.3M | ||
| Q4 25 | $114.0M | $66.6M | ||
| Q3 25 | $-117.1M | $39.8M | ||
| Q2 25 | $31.7M | $35.1M | ||
| Q1 25 | $42.8M | $41.4M | ||
| Q4 24 | $4.5M | $6.0M | ||
| Q3 24 | $85.9M | $-16.2M | ||
| Q2 24 | $146.0M | $35.4M |
毛利率
DOC
UVE
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 58.6% | — | ||
| Q2 25 | 60.2% | — | ||
| Q1 25 | 61.1% | — | ||
| Q4 24 | 60.3% | — | ||
| Q3 24 | 60.0% | — | ||
| Q2 24 | 60.6% | — |
营业利润率
DOC
UVE
| Q1 26 | 0.7% | — | ||
| Q4 25 | 17.4% | 21.7% | ||
| Q3 25 | 9.2% | 13.2% | ||
| Q2 25 | 5.7% | 11.6% | ||
| Q1 25 | 7.7% | 14.0% | ||
| Q4 24 | -2.2% | 1.9% | ||
| Q3 24 | 14.1% | -4.7% | ||
| Q2 24 | 22.3% | 12.6% |
净利率
DOC
UVE
| Q1 26 | 51.6% | 13.8% | ||
| Q4 25 | 73.2% | 16.3% | ||
| Q3 25 | -16.6% | 9.9% | ||
| Q2 25 | 4.6% | 8.8% | ||
| Q1 25 | 6.1% | 10.5% | ||
| Q4 24 | 0.7% | 1.6% | ||
| Q3 24 | 12.3% | -4.2% | ||
| Q2 24 | 21.0% | 9.3% |
每股收益(稀释后)
DOC
UVE
| Q1 26 | $0.28 | $1.88 | ||
| Q4 25 | $0.16 | $2.29 | ||
| Q3 25 | $-0.17 | $1.38 | ||
| Q2 25 | $0.05 | $1.21 | ||
| Q1 25 | $0.06 | $1.44 | ||
| Q4 24 | $0.02 | $0.23 | ||
| Q3 24 | $0.12 | $-0.57 | ||
| Q2 24 | $0.21 | $1.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $-1.2B | $595.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $7.8B | $584.7M |
| 总资产 | $21.6B | $2.8B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
DOC
UVE
| Q1 26 | $-1.2B | $595.8M | ||
| Q4 25 | $467.5M | $408.9M | ||
| Q3 25 | $91.0M | $405.1M | ||
| Q2 25 | $89.4M | $367.1M | ||
| Q1 25 | $70.6M | $398.2M | ||
| Q4 24 | $119.8M | $259.4M | ||
| Q3 24 | $180.4M | $333.7M | ||
| Q2 24 | $106.9M | $283.3M |
总债务
DOC
UVE
| Q1 26 | — | — | ||
| Q4 25 | $9.8B | $100.5M | ||
| Q3 25 | $9.1B | $100.7M | ||
| Q2 25 | $9.0B | $100.9M | ||
| Q1 25 | $8.9B | $101.1M | ||
| Q4 24 | $8.7B | $101.2M | ||
| Q3 24 | $8.6B | $101.4M | ||
| Q2 24 | $8.6B | $101.6M |
股东权益
DOC
UVE
| Q1 26 | $7.8B | $584.7M | ||
| Q4 25 | $7.5B | $551.0M | ||
| Q3 25 | $7.6B | $495.0M | ||
| Q2 25 | $7.9B | $457.8M | ||
| Q1 25 | $8.2B | $422.4M | ||
| Q4 24 | $8.4B | $373.3M | ||
| Q3 24 | $8.6B | $400.2M | ||
| Q2 24 | $8.8B | $393.2M |
总资产
DOC
UVE
| Q1 26 | $21.6B | $2.8B | ||
| Q4 25 | $20.3B | $2.8B | ||
| Q3 25 | $19.6B | $3.1B | ||
| Q2 25 | $19.8B | $3.3B | ||
| Q1 25 | $19.8B | $2.7B | ||
| Q4 24 | $19.9B | $2.8B | ||
| Q3 24 | $20.0B | $2.7B | ||
| Q2 24 | $20.2B | $2.7B |
负债/权益比
DOC
UVE
| Q1 26 | — | — | ||
| Q4 25 | 1.31× | 0.18× | ||
| Q3 25 | 1.20× | 0.20× | ||
| Q2 25 | 1.14× | 0.22× | ||
| Q1 25 | 1.08× | 0.24× | ||
| Q4 24 | 1.04× | 0.27× | ||
| Q3 24 | 1.00× | 0.25× | ||
| Q2 24 | 0.98× | 0.26× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOC
| Outpatient Medical | $320.5M | 46% |
| Lab | $217.6M | 31% |
| Senior Housing | $148.9M | 21% |
| Other | $14.3M | 2% |
| Corporate Non-segment | $1.5M | 0% |
UVE
暂无分部数据